Delta 9 Cannabis Third Quarter 2023 Earnings: CA$0.03 loss per share (vs CA$0.06 loss in 3Q 2022)
Delta 9 Cannabis (TSE:DN) Third Quarter 2023 Results
Key Financial Results
- Revenue: CA$18.4m (up 18% from 3Q 2022).
- Net loss: CA$5.48m (loss narrowed by 26% from 3Q 2022).
- CA$0.03 loss per share (improved from CA$0.06 loss in 3Q 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Delta 9 Cannabis Earnings Insights
Looking ahead, revenue is forecast to grow 8.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Pharmaceuticals industry in Canada.
Performance of the Canadian Pharmaceuticals industry.
The company's share price is broadly unchanged from a week ago.
Risk Analysis
Before we wrap up, we've discovered 5 warning signs for Delta 9 Cannabis (4 don't sit too well with us!) that you should be aware of.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSX:DN
Moderate and good value.
